Every fall, starting in mid-October, Americans over 65 enter what the insurance industry calls the Annual Enrollment Period — seven weeks during which Medicare beneficiaries can switch between Medicare Advantage plans, move from MA to traditional Medicare, or enroll in MA for the first time. The television advertising that saturates this period is among the most expensive and precisely targeted in American media. Joe Namath pitches plans with no monthly premium. William Shatner appears beside 800 numbers with promises of dental, vision, and grocery allowances. The ads run heavily on local news and daytime programming — the demographics that index highest for Medicare-eligible viewership.
The advertising is the visible surface of a much larger enrollment machinery. Beneath the television campaigns are direct mail operations, retail enrollment events at pharmacies and big-box stores, and a nationwide network of insurance brokers and agents whose compensation structure creates a direct financial incentive to enroll beneficiaries in Medicare Advantage plans regardless of whether MA is the better fit for their circumstances.
Medicare Advantage enrollment is not primarily driven by beneficiaries carefully comparing plan options and selecting the one that best meets their healthcare needs. It is driven by a commercial infrastructure built to find newly Medicare-eligible beneficiaries — particularly healthy ones — and convert them before they default to traditional Medicare’s relative simplicity. That distinction matters because the financial logic of Medicare Advantage depends on it.
The Financial Logic of Healthy Enrollment
The capitated rate the federal government pays a Medicare Advantage insurer is set based on the projected average cost of covering a Medicare beneficiary in a given county — adjusted upward for documented health conditions through the risk adjustment mechanism described in Article 04. A healthy 65-year-old who has just become Medicare-eligible represents, for an MA insurer, a highly favorable enrollment: the government pays a capitated rate calibrated for average Medicare costs, the enrollee is unlikely to use expensive specialist care or require hospitalization, and the margin between payment received and care delivered is maximized.
That margin is what funds the extra benefits — the dental allowances, vision coverage, fitness memberships, and transportation credits — that MA plans advertise to attract enrollment. The extra benefits are not philanthropy. They are paid for by the spread between the capitated payment and the cost of the care actually delivered to a population that, at the point of initial enrollment, skews significantly healthier than the traditional Medicare population.
Research has documented the favorable selection pattern consistently: MA enrollees are healthier on average at the point of enrollment than comparable traditional Medicare beneficiaries. The marketing machinery is not an incidental feature of the program. It is the mechanism by which the insurer manages its risk pool — finding and enrolling the beneficiaries who will generate the margin that makes the program financially viable for insurers.
The upcoding fraud documented in Article 05 is the other side of the same dynamic. MA insurers attract relatively healthy enrollees through marketing, then inflate the documented diagnoses of those enrollees through retrospective chart reviews and in-home health assessments to increase the risk-adjusted payment they receive from the government. The two mechanisms work together: favorable selection at enrollment, diagnosis inflation after enrollment.
The Broker Commission Structure
Insurance brokers and agents are the most consequential channel in Medicare Advantage enrollment. An estimated half of all MA enrollments involve a broker or agent. The commission structure that compensates them is the primary driver of steering — the documented practice of directing beneficiaries toward MA plans regardless of whether MA is the better fit.
The commission differential between Medicare Advantage and alternative Medicare coverage options is not subtle. CMS sets annual Fair Market Value maximums for MA broker commissions. For 2024, the national maximum initial enrollment commission for an MA plan was $611 per member per year, with renewal commissions capped at $306 — 50 percent of the initial rate. State-specific rates in markets like California and New Jersey ran as high as $762 to $780 for initial enrollments.
Traditional Medicare itself pays no broker commissions — there is no product to sell and no commission structure. A broker who enrolls a beneficiary in traditional Medicare earns nothing from that enrollment. The commissions available on the Medicare side come from supplemental products: standalone Part D prescription drug plans and Medigap supplement policies. The commission differential leaves a significant financial incentive in place for brokers to steer beneficiaries toward MA over traditional Medicare with a Medigap supplement, even when the beneficiary’s circumstances would be better served by the latter.
The commission structure created a secondary layer of incentives beyond the base commission: “administrative fees” paid by MA plans to brokers and to the Third-Party Marketing Organizations — the large intermediary firms that recruit, train, and deploy broker networks — on top of the standard per-enrollment commission. CMS identified this practice in regulatory proceedings as effectively rewarding steering, and attempted to eliminate administrative fees through its 2025 Final Rule. That rule was subsequently challenged in federal court by industry groups, and in August 2025 a federal court ruled the commission changes could not go into effect. The administrative fee structure the rule was designed to eliminate remained in place.
The Medicare Rights Center, in comments on the rulemaking, stated the central problem plainly: even with administrative fees addressed, the commission differential between MA enrollment and Medigap plus Part D enrollment leaves a structural incentive for brokers to favor MA. The incentive is built into the compensation architecture, and the compensation architecture is built into the program.
The Television and Direct Mail Apparatus
The celebrity endorsement model that dominates MA television advertising is not incidental to how the marketing works. Joe Namath, William Shatner, and other recognizable figures have appeared in campaigns for insurance marketing organizations — not for specific insurance carriers — pitching plans to Medicare-eligible audiences through the promise of “free” benefits that traditional Medicare does not cover.
The “no monthly premium” framing that leads much of MA advertising is technically accurate for some plans in some markets: some MA plans charge no additional premium beyond the Medicare Part B premium that all beneficiaries pay. The framing obscures what the zero-premium plan does not tell the prospective enrollee: that the network restricts which providers they can see, that prior authorization governs what services are covered, that the extra benefits have annual dollar limits and network restrictions, and that returning to traditional Medicare after developing a serious illness may require purchasing a Medigap policy at health-status-rated premiums — if a policy is available at all.
CMS has documented marketing rule violations across MA advertising consistently. OIG and state insurance commissioners have recorded complaints about advertising that misrepresents plan benefits, overstates coverage, and fails to disclose network and prior authorization requirements. The 2023 CMS marketing rule tightened standards for what MA advertising must disclose and prohibited certain misleading claims. The enforcement record — the gap between what the rules require and what CMS has the capacity to enforce — is addressed in the context of the extra benefits article.
Direct mail operations targeting newly Medicare-eligible beneficiaries begin well before the Annual Enrollment Period. Insurers and marketing organizations purchase lists of beneficiaries turning 65 and begin contact during the Initial Enrollment Period — the seven-month window around a beneficiary’s 65th birthday when they can first enroll in Medicare. The volume of mail received by newly eligible beneficiaries is substantial and deliberately confusing: multiple plans, varied benefit structures, limited disclosure of network and prior authorization requirements, and a uniform emphasis on the extra benefits that traditional Medicare does not offer.
The Retail Enrollment Event
The retail enrollment event — a staffed table at a pharmacy, grocery store, or community center during the Annual Enrollment Period — is a lower-visibility but significant enrollment channel, particularly for beneficiaries who are more receptive to in-person interaction than to television advertising or direct mail.
Enrollment events are staffed by brokers and agents working on commission. The structure of the event creates specific information asymmetries: the broker’s interest is in completing an enrollment; the beneficiary’s interest is in understanding whether MA is the right choice for their healthcare situation. What prospective enrollees are told about network restrictions, prior authorization requirements, and the consequences of enrollment for future Medigap coverage depends on the broker conducting the event and the regulatory oversight of that interaction.
CMS rules require brokers to provide beneficiaries with specific disclosures and prohibit certain sales tactics at enrollment events. OIG has documented violations of those rules. The practical enforcement capacity — the number of CMS staff monitoring enrollment events across a national retail footprint during a seven-week annual enrollment period — is limited.
Favorable Selection: How It Works
The marketing machinery produces a specific outcome: Medicare Advantage enrollment skews toward healthier beneficiaries than the traditional Medicare population. This is not a design flaw. It is the financial purpose of the marketing apparatus.
The mechanism operates through several channels simultaneously. The extra benefits that lead enrollment advertising — dental, vision, hearing, fitness memberships — are most valued by beneficiaries who are healthy enough to use them. A beneficiary managing multiple chronic conditions and frequent specialist visits cares primarily about whether their specialists are in the network and whether their medications are on the formulary. A healthy 65-year-old who has just retired cares about whether the plan covers dental care and gym access. MA plans design their benefit structures and marketing to reach the latter.
Network construction reinforces the selection effect. MA networks that exclude high-volume academic medical centers, specialized cancer centers, and the most in-demand subspecialists are unattractive to beneficiaries who need those providers. They are not unattractive to healthy 65-year-olds who do not. The network that looks like a limitation to a cancer patient looks like a non-issue to someone who hasn’t yet needed oncology.
Geographic targeting concentrates enrollment events and direct mail in communities with concentrations of newly Medicare-eligible beneficiaries who are more likely to be healthy — communities that index for recently retired, relatively affluent populations rather than communities with high rates of chronic illness and long-term Medicare enrollment.
The result is an enrollment population that is, at the point of entry, healthier on average than the traditional Medicare beneficiaries paying the same Part B premium and eligible for the same coverage. The capitated payment the government makes to the MA insurer is calibrated for average Medicare costs, not for this healthier-than-average population. The margin between payment and care cost is the financial engine of the extra benefits and the insurer’s profit structure.
The Switcher Problem
What the enrollment advertising does not tell the beneficiary enrolling at 65 is what returning to traditional Medicare will look like if they develop a serious illness while enrolled in a Medicare Advantage plan.
The path back to traditional Medicare is open in the sense that disenrollment is legally permitted during designated enrollment periods. What is not guaranteed is the ability to purchase a Medigap supplement policy — the coverage that makes traditional Medicare comprehensive by covering cost-sharing — after enrollment in MA has begun.
Federal law guarantees Medigap coverage without health-status underwriting — guaranteed-issue rights — at specific moments: when a beneficiary first becomes eligible for Medicare at 65, and during certain qualifying events. In most states, those guaranteed-issue rights do not extend to beneficiaries who have been enrolled in Medicare Advantage and later want to return to traditional Medicare. A beneficiary who enrolled in MA at 65 when they were healthy, develops cancer at 72 while enrolled in an MA plan, and then attempts to disenroll to traditional Medicare — seeking the unrestricted provider access that traditional Medicare provides — may find that Medigap insurers in their state can underwrite based on their cancer diagnosis, charge substantially higher premiums, or decline to issue a policy at all.
This dynamic — that the enrollment decision made at 65 by a healthy beneficiary who had no reason to think carefully about MA’s limitations may bind them at 72 when those limitations become consequential — is not disclosed in MA enrollment advertising. It is the switcher problem, and it is the subject of full treatment in Article 11 of this hub.
The coverage map instruction is to flag it here and not develop it fully. The flag belongs here because the marketing machinery that drives enrollment at 65 is the upstream cause of the lock-in problem that manifests at 72. The two are the same story at different points in the beneficiary’s enrollment trajectory.
CMS Oversight and Its Limits
CMS has regulatory authority over Medicare Advantage marketing. It sets the rules that govern what plans can and cannot claim in advertising, what brokers must disclose in enrollment interactions, what commission structures are permitted, and what constitutes a marketing rule violation subject to enforcement.
The gap between regulatory authority and enforcement capacity is a recurring finding across OIG and GAO reviews of MA marketing oversight. The volume of MA marketing activity — tens of millions of direct mail pieces, thousands of television and radio advertisements, tens of thousands of enrollment events across the country during the Annual Enrollment Period — exceeds CMS’s practical capacity to monitor. Complaint resolution is slow, fines are modest relative to the revenue generated by enrollment, and the most consequential enforcement actions — plan sanctions that would affect enrollment — are rare.
The 2023 CMS marketing rule represented the most significant tightening of MA marketing standards in years. It restricted misleading benefit claims, tightened disclosure requirements, and attempted to address the administrative fee layer of broker compensation. The rule’s implementation has been partial: the commission provisions were challenged in court and blocked, and the marketing disclosure provisions face an enforcement apparatus that the rulemaking itself did not substantially expand.
The Medicare Rights Center’s assessment of the 2024 final rule stated the structural problem directly: eliminating administrative fees without addressing the underlying commission differential between MA and Medigap left the primary steering incentive intact. The marketing machinery that builds the favorable-selection enrollment base does not require administrative fees to function. It requires only that enrolling a beneficiary in MA pay more than enrolling them in the alternative — and it does, by a wide margin.
What the Marketing Machine Produces
The Medicare Advantage marketing apparatus produces a specific outcome at scale: an enrolled population that is healthier than the Medicare average, enrolled through a commercial infrastructure whose financial interest is in enrollment volume rather than beneficiary welfare, through advertising that emphasizes benefits the plan offers and does not disclose the coverage limitations that matter most when the beneficiary’s health declines.
The program’s financial structure depends on this outcome. Without favorable selection — without an enrolled population that is meaningfully healthier than the average Medicare beneficiary — the extra benefits would not be affordable at zero or low premium, the insurer’s margin would compress, and the marketing investment that drives enrollment would not generate adequate return.
The downstream consequences of that enrollment — the prior authorization denials, the network gaps, the disenrollment at end of life — are documented in the articles that follow. They are the back end of the same machine whose front end is the television advertisement promising free dental care to the healthy 65-year-old who just retired.
The complete Medicare Advantage series
01 — What Medicare Advantage Actually Is — and How It Replaced Traditional Medicare
02 — The Political History: How Private Insurers Got Into Medicare
03 — The Marketing Machine: How Enrollment Works and Who It Targets
04 — Risk Adjustment: The Payment System That Rewards Diagnosis, Not Treatment
05 — The $84 Billion Overpayment: How Upcoding Works at Scale
06 — The Profit Extraction Model: What Insurers Take Before Care Is Delivered
07 — Prior Authorization in Medicare Advantage: What OIG Found
08 — The Denial and Appeals Record: What Happens When Enrollees Push Back
09 — Network Adequacy and the Coverage Gap
10 — The Extra Benefits Myth: Dental, Vision, and What the Fine Print Says
11 — When Medicare Advantage Fails: Disenrollment at the End of Life
12 — The Reform Proposals: From Audit Reform to Elimination
13 — What the Evidence Resolves — and What It Doesn’t
This article was researched and drafted with AI assistance under human review. See our full AI and editorial practices.